Most bought healthcare stocks in Q3 2016
See which Healthcare stocks institutional investors increased the most in Q3 2016, measured as net growth in reported share positions from Q2 2016 into Q3 2016. Notable additions at the top of this list include ASTRAZENECA PLC-SPONS ADR (AZN), PFIZER INC (PFE), BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC-SPONS ADR | 13,569,437 | $548.75M | 1 | 1 | 1 | 0 | 4 |
| PFE | PFIZER INC | 7,359,344 | $225.74M | 0 | 7 | 6 | 1 | 14 |
| BMY | BRISTOL-MYERS SQUIBB CO | 4,569,664 | $223.08M | 1 | 3 | 4 | 0 | 11 |
| SNY | SANOFI-ADR | 4,115,835 | -$62.26M | 0 | 3 | 1 | 0 | 6 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2,740,726 | $216.93M | 0 | 1 | 0 | 1 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | 2,595,529 | $291.23M | 1 | 2 | 1 | 0 | 4 |
| HCA | HCA HEALTHCARE INC | 2,569,211 | $190.20M | 2 | 1 | 1 | 1 | 5 |
| MCK | MCKESSON CORP | 2,349,025 | $365.67M | 1 | 2 | 1 | 1 | 7 |
| GILD | GILEAD SCIENCES INC | 2,095,248 | $103.56M | 0 | 9 | 3 | 2 | 13 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 2,077,977 | $254.59M | 1 | 2 | 0 | 1 | 3 |
| PDCO | PATTERSON COS INC | 2,001,611 | $74.13M | 1 | 3 | 2 | 0 | 6 |
| EXEL | EXELIXIS INC | 1,868,450 | $23.90M | 1 | 0 | 0 | 0 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1,705,586 | -$87.07M | 0 | 2 | 0 | 0 | 2 |
| OPK | OPKO HEALTH INC | 1,412,757 | $14.96M | 1 | 0 | 0 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | 1,225,569 | -$5.42M | 0 | 1 | 1 | 1 | 2 |
| ELV | ELEVANCE HEALTH INC | 1,099,330 | $74.85M | 1 | 2 | 3 | 0 | 8 |
| HUM | HUMANA INC | 1,051,426 | $180.30M | 1 | 1 | 1 | 1 | 3 |
| XRAY | DENTSPLY SIRONA INC | 971,717 | $56.25M | 1 | 1 | 2 | 0 | 4 |
| ARAY | ACCURAY INC | 967,723 | $10.08M | 0 | 1 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 944,800 | $30.25M | 1 | 1 | 0 | 0 | 2 |
| DHR | DANAHER CORP | 880,421 | -$396.85M | 1 | 5 | 2 | 1 | 9 |
| OSUR | ORASURE TECHNOLOGIES INC | 872,700 | $13.34M | 0 | 1 | 0 | 0 | 1 |
| COR | CENCORA INC | 832,860 | $68.57M | 1 | 1 | 0 | 1 | 2 |
| ABBV | ABBVIE INC | 777,869 | $52.78M | 1 | 3 | 1 | 0 | 12 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 638,829 | $11.85M | 0 | 1 | 0 | 0 | 1 |
| RMD | RESMED INC | 632,900 | $42.23M | 0 | 1 | 0 | 0 | 1 |
| GKOS | GLAUKOS CORP | 580,800 | $22.99M | 0 | 1 | 0 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 572,100 | $9.83M | 1 | 0 | 0 | 0 | 1 |
| EGRX | EAGLE PHARMACEUTICALS INC | 568,205 | $39.77M | 1 | 0 | 0 | 0 | 1 |
| ENTA | ENANTA PHARMACEUTICALS INC | 549,200 | $15.31M | 0 | 1 | 0 | 0 | 1 |
| HOLX | HOLOGIC INC | 547,548 | $27.49M | 1 | 0 | 1 | 0 | 3 |
| OMI | OWENS & MINOR INC | 492,700 | $15.92M | 0 | 1 | 0 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 491,400 | $32.00M | 0 | 1 | 0 | 0 | 1 |
| CTLT | CATALENT INC | 489,900 | $12.66M | 1 | 0 | 0 | 0 | 1 |
| PTCT | PTC THERAPEUTICS INC | 450,800 | $7.03M | 0 | 1 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 420,300 | $1.75M | 0 | 1 | 0 | 1 | 1 |
| WAT | WATERS CORP | 413,312 | $140.61M | 1 | 2 | 1 | 0 | 4 |
| HALO | HALOZYME THERAPEUTICS INC | 394,500 | $29.26M | 1 | 1 | 0 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 365,300 | $6.78M | 1 | 0 | 0 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | 327,371 | $10.59M | 1 | 0 | 1 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 321,016 | $35.06M | 1 | 0 | 1 | 0 | 2 |
| ESPR | ESPERION THERAPEUTICS INC | 318,800 | $4.42M | 1 | 0 | 0 | 0 | 1 |
| INCY | INCYTE CORP | 306,439 | $35.22M | 1 | 0 | 2 | 0 | 3 |
| MCRB | SERES THERAPEUTICS INC | 296,500 | $3.64M | 1 | 0 | 0 | 0 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | 281,000 | $5.50M | 0 | 1 | 0 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | 255,893 | -$159.86M | 0 | 4 | 3 | 0 | 9 |
| CARA | CARA THERAPEUTICS INC | 247,900 | $2.07M | 1 | 0 | 0 | 0 | 1 |
| FGEN | FIBROGEN INC | 223,300 | $4.62M | 1 | 0 | 0 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 199,300 | $6.19M | 0 | 1 | 0 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 196,400 | $1.45M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2016
What are the most bought Healthcare stocks in Q3 2016?
The most bought healthcare stocks in Q3 2016 are those with the largest increase in reported share counts across institutional investors compared to Q2 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2016?
Among filers in this sector, net additions were largest in companies such as ASTRAZENECA PLC-SPONS ADR (AZN), PFIZER INC (PFE), BRISTOL-MYERS SQUIBB CO (BMY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.